BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 133 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2018. The put-call ratio across all filers is 0.63 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $8,974,000 | -42.9% | 239,000 | -39.9% | 0.32% | -41.8% |
| Q2 2018 | $15,729,000 | -29.7% | 398,000 | -54.2% | 0.55% | -28.9% |
| Q1 2018 | $22,385,000 | +143.3% | 869,000 | +154.8% | 0.78% | +114.4% |
| Q4 2017 | $9,200,000 | +49.2% | 341,000 | +106.7% | 0.36% | +30.2% |
| Q3 2017 | $6,168,000 | +13.8% | 165,000 | -23.9% | 0.28% | -3.8% |
| Q2 2017 | $5,419,000 | – | 216,761 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 710,422 | $24,658,747 | 16.62% |
| Birchview Capital, LP | 7,365 | $255,639 | 0.24% |
| Itau Unibanco Holding S.A. | 88 | $3,054 | 0.00% |